Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2020

01-01-2020 | Breast Cancer | Correction

Correction to: The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1

Authors: Lufeng Zheng, Xiaoman Li, Yi Gu, Xiaobo Lv, Tao Xi

Published in: Breast Cancer Research and Treatment | Issue 2/2020

Login to get access

Excerpt

After publication of this article [1], it came to our attention that there was an error in Fig. 4b, c. In Fig.4b, the migration images of vector groups were incorrect based on this error, the authors re-constructed the migration experiments of Fig. 4b, and the consistent results were obtained. In Fig. 4c, the tube formation image of the Z2P-UTR-siRNA&Z1-UTR group (MCF-7) of Fig. 7d was accidentally misused in control group (MCF-7) and vector group (MCF-7) of Fig. 4c. The corrected Fig. 4 is provided below. This error did not impact the conclusions of the article. The authors apologize for this error. …
Literature
1.
Zheng L, Li X, Gu Y, Lv X, Xi T (2015) The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1. Breast Cancer Res Treat 150(1):105–118CrossRef
Metadata
Title
Correction to: The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1
Authors
Lufeng Zheng
Xiaoman Li
Yi Gu
Xiaobo Lv
Tao Xi
Publication date
01-01-2020
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2020
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05478-4

Other articles of this Issue 2/2020

Breast Cancer Research and Treatment 2/2020 Go to the issue

Editorial

Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction

Epidemiology

Patient-reported cosmetic satisfaction and the long-term association with quality of life in irradiated breast cancer patients

Clinical Trial

Fulvestrant and palbociclib combination in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer patients

Preclinical study

Molecular determinants of drug response in TNBC cell lines

Epidemiology

Flat epithelial atypia: are we being too aggressive?

Clinical trial

Breast cancer survivorship care plans: what are they covering and how well do they align with national guidelines?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits